Ionolyte, otopina za infuziju
| Name | Ionolyte, otopina za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-478143033 |
| Active Substance | natrijev acetat trihidrat, natrijev klorid, kalijev klorid, magnezijev klorid heksahidrat |
| Composition | 1000 ml otopine za infuziju sadrži 4,63 g natrijevog acetata trihidrata, 6,02 g natrijeva klorida, 0,30 g kalijevog klorida i 0,30 g magnezijevog klorida heksahidrata |
| Pharmaceutical Form | otopina za infuziju |
| Manufacturer | Fresenius Kabi Deutschland GmbH, Friedberg, Njemačka Fresenius Kabi France, Louviers, Francuska |
| Marketing Authorisation Holder | Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, Hrvatska |
| Marketing Authorisation Date | 14.10.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/252 |
| Registration Number | 381-12-01/30-20-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | B05BB01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |